WHO ICTRP trial
EUCTR2015-001402-34-FR · CHRU de Brest
EUCTR2015-001402-34-FR · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2015-001402-34-FR |
|---|---|
| Primary sponsor | CHRU de Brest |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): yes Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): no |
| Countries | France |
| Conditions | MedDRA version: 20.0 Level: LLT Classification code 10066055 Term: Upper limb paresis System Organ Class: 100000004852 ;Therapeutic area: Not possible to specify |
| Interventions | Trade Name: BOTOX Product Name: Toxine Botulique Pharmaceutical Form: Solution for injection Pharmaceutical form of the placebo: Solution for injection Route of administration of the placebo: Intramuscular use |
| Registration date | Oct 27, 2016 |
| Target size | 62 |
| Secondary IDs | RB15.050 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: